Gold nanorod bioconjugates for active tumor targeting and photothermal therapy
Journal of Nanotechnology, ISSN: 1687-9503, Vol: 2011, Page: 1-7
2011
- 21Citations
- 22Usage
- 59Captures
- 3Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations21
- Citation Indexes21
- 21
- CrossRef13
- Usage22
- Abstract Views22
- Captures59
- Readers59
- 59
- Mentions3
- References2
- Wikipedia2
- News Mentions1
- News1
Most Recent News
Hadiyah-Nicole Green Targets Cancer With Lasers
Spurred by family tragedy, the medical physicist wants to treat cancer in a new way.
Article Description
The mastery of active tumor targeting is a great challenge in near infrared photothermal therapy (NIRPTT). To improve efficiency for targeted treatment of malignant tumors, we modify the technique of conjugating gold nanoparticles to tumor-specific antibodies. Polyethylene glycol-coated (PEGylated) gold nanorods (GNRs) were fabricated and conjugated to an anti-EGFR antibody. We characterized the conjugation efficiency of the GNRs by comparing the efficiency of antibody binding and the photothermal effect of the GNRs before and after conjugation. We demonstrate that the binding efficiency of the antibodies conjugated to the PEGylated GNRs is comparable to the binding efficiency of the unmodified antibodies and 33.9% greater than PEGylated antibody-GNR conjugates as reported by Liao and Hafner (2005). In addition, cell death by NIRPTT was sufficient to kill nearly 90% of tumor cells, which is comparable to NIRPTT with GNRs alone confirming that NIRPTT using GNRs is not compromised by conjugation of GNRs to antibodies. Copyright © 2011 Hadiyah N. Green et al.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84855278508&origin=inward; http://dx.doi.org/10.1155/2011/631753; http://www.hindawi.com/journals/jnt/2011/631753/; http://downloads.hindawi.com/journals/jnt/2011/631753.pdf; http://downloads.hindawi.com/journals/jnt/2011/631753.xml; https://www.airitilibrary.com/Article/Detail/P20160523005-201112-201705120032-201705120032-267-273; https://dx.doi.org/10.1155/2011/631753; https://www.hindawi.com/journals/jnt/2011/631753/
Hindawi Limited
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know